The medicine, called Vipdervir, is capable of preventing SARS-CoV-2 from sticking to host cells, or in any case activating immune cells so that they can recognize, block, and eliminate the viral particles, Chu Hoang Ha, vice president of the Vietnam Academy of Science and Technology (VAST), explained.

Synthesized as of medicinal herbs whose names the scientist did not reveal, the medication remains under evaluation for its safety, stability and capability to inhibit the spread of the deadly virus, as well as A/H5N1 influenza.

If the research is successful, as it appears to be, the relevant studies will be carried out to master the manufacturing technology of Vipdervir and turn it into a new tool in the anti-Covid-19 treatment.

The VAST’s Institute of Biotechnology, the Vinh Gia Pharmaceutical JSC and the Vietnam Chemical Pharmaceutical JSC are participating in the research.

pgh/iff/jcm/asg